Endotronix Stock

endotronix.comHealthcare / Other HealthcareFounded: 2007Funding to Date: $130.19MM

Endotronix is a digital health medtech company and developer of an integrated platform designed to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure.

Register To Buy and Sell Shares

For more details on financing and valuation for Endotronix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Endotronix’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Endotronix.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Nicolas Chronos MD
Executive Vice President, Strategy & Clinical Affairs
Tyler Panian
Director of Mechanical Engineering
Michael Nagy
Co-Founder & Chief Technology Officer
Katrin Leadley MD
Chief Medical Officer
Harry Rowland Ph.D
Co-Founder, Chief Executive Officer & Board Member
John Flavin
Chief Financial Officer

Board Members

Harry Rowland Ph.D
Paul LaViolette
SV Health Investors
Stanley Lynall
OSF Ventures
Gerry Brunk
Lumira Ventures
James Hummer
Robert Zieserl
Fouad Azzam Ph.D
Life Sciences Partners
Jennifer McMahon
Seroba Life Sciences
Marc Goldberg JD
BioVentures Investors

Frequently Asked Questions About Endotronix’s Stock

Can you buy Endotronix’s stock?
Endotronix is not publicly traded on NYSE or NASDAQ in the U.S. To buy Endotronix’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Endotronix’s stock?
Yes, you can sell stock of a private company like Endotronix. Forge can help you sell your Endotronix stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Endotronix’s stock price?
Endotronix is a privately held company and therefore does not have a public stock price. However, you may access Endotronix’s private market stock price with Forge Data.
What is Endotronix’s stock ticker symbol?
Endotronix does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Endotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution
/PRNewswire/ -- Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion...
Endotronix closes $45m Series D
Endotronix said today that it closed on a $45 million Series D round for the Cordella cardiovascular monitoring technology it’s developing. The Lisle, Ill.-based company said its latest raise was led by LSP and included Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments and an unnamed […]
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.